SERIAL ASSESSMENT OF BONE MARROW (BM) COLONY FORMING CAPACITY (CFC) IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) [PDF]
, 1977 Naomi L.C. Luban, Denis R. Miller
openalex +1 more source
JPGN Reports, EarlyView.Abstract Asparaginase is a critical component of modern therapy for acute lymphoblastic leukemia (ALL). Its use has improved cure rates for both children and adults with this disease. However, asparaginase therapy can be complicated by significant toxicities, including acute pancreatitis (AP).
Jodie Greear +7 more
wiley +1 more source
Interrelationship of immunologic characteristics, proliferation pattern, and prednisone sensitivity in acute lymphoblastic leukemia of childhood [PDF]
, 1979 JA Bakkeren, GA de Vaan, HF Hillen
openalex +1 more source
JEADV Clinical Practice, EarlyView.ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer +3 more
wiley +1 more source
Acute and long-term neurological complications in children with acute lymphoblastic leukemia
, 1970 Asifur Rahman +2 more
openalex +2 more sources
Translocation t(1;19)(q21;q13) in acute lymphoblastic leukemia [PDF]
, 1984 Christiane Werner‐Favre +3 more
openalex +1 more source
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
JEADV Clinical Practice, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source
Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens [PDF]
, 1983 MP Braun +3 more
openalex +1 more source
Blinatumomab in acute lymphoblastic leukemia [PDF]
Expert Review of Anticancer Therapy, 2016 Caroline Lejeune, Xavier Thomas
openaire +4 more sources
USP28 Promotes Osimertinib Resistance in H1975 NSCLC Cells by Deubiquitinating and Stabilizing SIRT1
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Osimertinib (OSI) resistance in non‐small cell lung cancer (NSCLC) remains a significant challenge. This report explored the precise role of USP28 on OSI resistance in NSCLC and identified a functional downstream effector. OSI‐resistant H1975 cells (H1975/OSI) were established by long‐term OSI exposure.
Hu‐Sen Fan +4 more
wiley +1 more source